From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
The approval of new prescription-free glucose biosensors has significantly broadened access to continuous glucose monitoring (CGM) technology for various populations, including those with prediabetes and...
In part one of this four-part series on diabetes technology, Lisa Jones, MA, RDN, LDN, FAND, interviews Grace A. Derocha, MBA, RD, CDCES, a registered dietitian, certified diabetes care and education...
In this video, Angela Golden, DNP, FNP-C, discusses evidence-based approaches in the management of patients with obesity, including the use of medications, surgery, and controversies.
In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with...
In this podcast, Diana Isaacs, PharmD, CDCES, talks about continuous glucose monitoring (CGM) technology and how it can be used for medicine adjustments and lifestyle interventions for patients with...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about how clinicians can individualize care for their patients with type 2 diabetes, including strategies that can be used, what...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...
